Drugplain

XTAMPZA ER 36 mg/1

OXYCODONE · CAPSULE, EXTENDED RELEASE · Collegium Pharmaceutical, Inc.

No Recall HistoryCurrently in Shortage
Plain English

XTAMPZA ER is a capsule, extended release containing oxycodone at 36 mg/1, taken oral. Manufactured by Collegium Pharmaceutical, Inc..

Key Facts

Brand Name
XTAMPZA ER
Generic Name
OXYCODONE
NDC Code (Product)
24510-140
Manufacturer
Collegium Pharmaceutical, Inc.
Strength
36 mg/1
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
NDA208090
Drug Class
Opioid Agonist [EPC]
Marketing Start
05/10/2016

Recall History

No Recall History

Frequently Asked Questions

What is XTAMPZA ER used for?

XTAMPZA ER contains OXYCODONE. It is a capsule, extended release taken oral. Consult your doctor for specific uses.

Is XTAMPZA ER a controlled substance?

Yes, XTAMPZA ER is classified as CII under the DEA Controlled Substances Act.

What is the generic name for XTAMPZA ER?

The generic name for XTAMPZA ER is OXYCODONE. There are 12 other brand versions of OXYCODONE.

What is the NDC code for XTAMPZA ER 36 mg/1?

The NDC (National Drug Code) for XTAMPZA ER 36 mg/1 is 24510-140, listed by Collegium Pharmaceutical, Inc..